Invacare names new senior vice president and general counsel
Mr LaPlaca will be responsible for all legal affairs, risk management and intellectual property matters at the company and also will serve as the corporate secretary. Mr LaPlaca
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.